IDENTIFYING PATIENTS AT RISK FOR THROMBOEMBOLISM - USE OF I-125-LABELED FIBRINOGEN IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

被引：18

作者：

CRISTAL, N

STERN, J

RONEN, M

SILVERMAN, C

HO, W

BARTOV, E

机构：

[1] SOROKA MED CTR,CORONARY SERV,INTENS CORONARY CARE UNIT,BEERSHEBA,ISRAEL

[2] SOROKA MED CTR,MED DEPT B,BEERSHEBA,ISRAEL

[3] SOROKA MED CTR,INST ISOTOPE,BEERSHEBA,ISRAEL

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1976年 / 236卷 / 24期

关键词：

D O I：

10.1001/jama.236.24.2755

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2755 / 2757

页数：3

共 17 条

[1]

[Anonymous], 1969, Br Med J, V1, P335

[2]

ATKINS P, 1965, LANCET, V2, P1217

[3]

BROWSE, 1972, AM HEART J, V84, P149

[4] USE OF ANTICOAGULANTS IN ACUTE MYOCARDIAL-INFARCTION [J].

EBERT, RV .

CIRCULATION, 1972, 45 (04) :903-+

[5]

FLAC C, 1969, LANCET, V1, P477

[6]

HILDEN T, 1961, LANCET, V2, P327

[7]

KAKKAR VV, 1970, LANCET, V1, P540

[8]

KOTILAINEN M, 1973, ANN CLIN RES, V5, P365

[9] DIAGNOSTIC ACCURACY IN VENOUS THROMBOSIS [J].

LAMBIE, JM ;

MAHAFFY, RG ;

BARBER, DC ;

KARMODY, AM ;

SCOTT, MM ;

MATHESON, NA .

BMJ-BRITISH MEDICAL JOURNAL, 1970, 2 (5702) :142-+

[10]

MAURER BJ, 1971, LANCET, V2, P1385

← 1 2 →